Skip to main content

The Latest

  • Dr. Joel M. Schwartz
    Joel M. Schwartz, DO increases your knowledge regarding skin cancer awareness
    Recently held, World Cancer Day 2015 took ”a positive and proactive approach to the fight against cancer.” I was thrilled when the opportunity came about for me to ask some questions, and get the viewpoint regarding skin cancer and...
  • Infantile Eczema
    Study: Eczema cream for kids not linked to increased cancer risk
    A new study may put to rest parents’ concerns about the use of pimecrolimus (brand name Elidel) to treat their children’s eczema. The research, published in in the Feb. 18 online issue of JAMA Dermatology, found that the topical cream ...
  • tanning bed
    Tanning and melanoma: What are the real risks?
    Since we live in an age of technology, medicine, and science that would seem almost magical just a few short generations ago, it's easy to lose sight of the fact that there are many questions we still don't know the answers to. One of...
  • Coffee offers protection against malignant melanoma
    Coffee offers protection against malignant melanoma
    Sure, you’ve heard plenty of bad things about coffee—it stains your teeth and all—but here’s some info that seems to encourage you to drink coffee, and lots of it. According to CBS News on Tuesday, the newest study has...
  • UCLA makes progress on war against melanoma
    UCLA makes progress on war against melanoma
    Research on melanoma, a deadly skin cancer, is ongoing UCLA Jonsson Comprehensive Cancer Center. The results of their latest advance was published online on January 15 in the journal Cancer Cell. The researchers have discovered how melanoma...
  • Cancer Survivorship Coping Tools - We'll get you through this
    Home Organizing Examiner Changes Direction As Two-Time Cancer Survivor
    Yes, this is about me and a radical change of direction. Since 1998, I taught clutter clearing and home organizing as a professional motivational speaker and published writer. In that capacity, I wrote for the Examiner. In early 2010, I wrote a...
  • Children of melanoma survivors are avoiding proper sun protection
    Children of melanoma survivors are avoiding proper sun protection
    Researchers at UCLA Jonsson Comprehensive Cancer Center (JCCC) have made a troubling discovery. Children of melanoma survivors are not optimally following sun protection recommendations. This is of significant concern because sunburns are a major...
  •  Opdivo given accelerated approval to treat inoperable melanoma
    Opdivo given accelerated approval to treat inoperable melanoma
    The FDA has granted accelerated approval to Opdivo (nivolumab), a new treatment for patients with inoperable or metastatic melanoma which no longer respond to other medications. The drug works by inhibiting the PD-1 protein on cells, which blocks...
  • Maryland cancer advocates push to  restrict use of tanning beds in 2015
    Maryland cancer advocates push to restrict use of tanning beds in 2015
    Over the past several years, a variety of bills have been submitted to the Maryland General Assembly. In general the bills asked that those under the age of 18 be restricted from using tanning beds. Some of them referenced the requirement of a...
  • UCLA study paves the way to more effective melanoma treatment
    UCLA study paves the way to more effective melanoma treatment
    Last September, the Food and Drug Administration (FDA) approved pembrolizumab, which was found to be affective against melanoma, a deadly form of skin cancer. Sadly, not all melanoma patients benefit from the treatment and UCLA Jonsson...
  • New melanoma treatment boosts survival and has less side-effects
    New melanoma treatment boosts survival and has less side-effects
    A new study by researchers at UCLA's Jonsson Comprehensive Cancer Center (JCCC) describes a new treatment that combines the drug Zelboraf® (vemurafenib) with an experimental drug cobimetinib for metastatic melanoma, a deadly form of skin...
  • Keytruda found to be key in treating advanced melanoma
    Keytruda found to be key in treating advanced melanoma
    Accelerated approval of the drug Keytruda (pembrolizumab) has been granted by the FDA for the treatment of patients with advanced or unresectable melanoma who are no longer responding to other drugs. The National Cancer Institute now estimates...
  • let he among us
    On Merck: FDA and the Bible have something in common
    According to a September 4 article in the Star Tribune; the Food and Drug Administration has given “accelerated” approval to Merck. This approval allows Merck to market and sell Keytruda, a drug that can be used to treat melanoma....
  • FDA approves promising melanoma drug Keytruda
    FDA approves promising melanoma drug Keytruda
    Melanoma is a deadly form of skin cancer because it has the ability to metastasize (spread) to many sites, including the brain, lungs, and liver. On September 4, the Food and Drug Administration (FDA) approved Keytruda (pembrolizumab) for the...
  • US teens shunning sunscreen reports new study
    US teens shunning sunscreen reports new study
    According to a new study, less US teens are using sunscreen while the rates of skin cancer including, deadly melanoma, are increasing. In addition, the use of tanning salons is increasing. The findings are of particular importance to residents of...